AstraZeneca Statistics

Total Valuation

AstraZeneca has a market cap or net worth of SEK 2.70 trillion. The enterprise value is 2.93 trillion.

Market Cap	2.70T
Enterprise Value	2.93T

Important Dates

The next confirmed earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	Feb 19, 2026

Share Statistics

Current Share Class	1.55B
Shares Outstanding	n/a
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	68.01%
Float	1.54B

Valuation Ratios

The trailing PE ratio is 28.66 and the forward PE ratio is 18.27.

PE Ratio	28.66
Forward PE	18.27
PS Ratio	4.99
PB Ratio	6.02
P/TBV Ratio	n/a
P/FCF Ratio	24.91
P/OCF Ratio	20.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.97, with an EV/FCF ratio of 26.98.

EV / Earnings	31.04
EV / Sales	5.35
EV / EBITDA	15.97
EV / EBIT	21.99
EV / FCF	26.98

Financial Position

The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.61.

Current Ratio	0.94
Quick Ratio	0.65
Debt / Equity	0.61
Debt / EBITDA	1.51
Debt / FCF	2.52
Interest Coverage	10.47

Financial Efficiency

Return on equity (ROE) is 22.84% and return on invested capital (ROIC) is 16.48%.

Return on Equity (ROE)	22.84%
Return on Assets (ROA)	8.19%
Return on Invested Capital (ROIC)	16.48%
Return on Capital Employed (ROCE)	17.12%
Weighted Average Cost of Capital (WACC)	5.58%
Revenue Per Employee	5.63M
Profits Per Employee	980,712
Employee Count	96,100
Asset Turnover	0.54
Inventory Turnover	1.81

Taxes

In the past 12 months, AstraZeneca has paid 19.99 billion in taxes.

Income Tax	19.99B
Effective Tax Rate	17.49%

Stock Price Statistics

The stock price has increased by +28.74% in the last 52 weeks. The beta is 0.28, so AstraZeneca's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+28.74%
50-Day Moving Average	1,823.05
200-Day Moving Average	1,645.25
Relative Strength Index (RSI)	33.86
Average Volume (20 Days)	231,079

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AstraZeneca had revenue of SEK 541.41 billion and earned 94.25 billion in profits. Earnings per share was 60.28.

Revenue	541.41B
Gross Profit	442.36B
Operating Income	131.73B
Pretax Income	114.31B
Net Income	94.25B
EBITDA	177.71B
EBIT	131.73B
Earnings Per Share (EPS)	60.28

Balance Sheet

The company has 52.71 billion in cash and 273.78 billion in debt, giving a net cash position of -221.07 billion.

Cash & Cash Equivalents	52.71B
Total Debt	273.78B
Net Cash	-221.07B
Net Cash Per Share	n/a
Equity (Book Value)	449.06B
Book Value Per Share	289.23
Working Capital	-17.46B

Cash Flow

In the last 12 months, operating cash flow was 134.34 billion and capital expenditures -25.90 billion, giving a free cash flow of 108.44 billion.

Operating Cash Flow	134.34B
Capital Expenditures	-25.90B
Depreciation & Amortization	46.24B
Net Borrowing	-18.74B
Free Cash Flow	108.44B
FCF Per Share	n/a

Margins

Gross margin is 81.71%, with operating and profit margins of 24.33% and 17.41%.

Gross Margin	81.71%
Operating Margin	24.33%
Pretax Margin	21.11%
Profit Margin	17.41%
EBITDA Margin	32.82%
EBIT Margin	24.33%
FCF Margin	20.03%

Dividends & Yields

This stock pays an annual dividend of 29.30, which amounts to a dividend yield of 1.68%.

Dividend Per Share	29.30
Dividend Yield	1.68%
Dividend Growth (YoY)	-13.19%
Years of Dividend Growth	4
Payout Ratio	47.39%
Buyback Yield	0.06%
Shareholder Yield	1.74%
Earnings Yield	3.49%
FCF Yield	4.01%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AstraZeneca has an Altman Z-Score of 3.24 and a Piotroski F-Score of 7.

Altman Z-Score	3.24
Piotroski F-Score	7